loading
  • Trang chủ
  • Sách, tuyển tập
  • Systematic review and meta-analysis of the quality-of-life of patients with Parkinson’s disease / Zahra Hoseinipalangi;Fatemeh Pashazadeh Kan;Hossein Hosseinifard;Maryam Doustmehraban;Maryam Masoumi;Sima Rafiei;Pooyan Barmayoon;Niloofar Ahmadi;Batool Sadat Hoseini;Afsaneh Dehnad;Hajar Eshtod;Mahsa Tohidi Asl;Mahmoud Nasiri;Moslem Arian;Sepideh Aghalou;Ahmad Ghashghaee
Sách, tuyển tập Tài liệu điện tử

Systematic review and meta-analysis of the quality-of-life of patients with Parkinson’s disease / Zahra Hoseinipalangi;Fatemeh Pashazadeh Kan;Hossein Hosseinifard;Maryam Doustmehraban;Maryam Masoumi;Sima Rafiei;Pooyan Barmayoon;Niloofar Ahmadi;Batool Sadat Hoseini;Afsaneh Dehnad;Hajar Eshtod;Mahsa Tohidi Asl;Mahmoud Nasiri;Moslem Arian;Sepideh Aghalou;Ahmad Ghashghaee

Tác giả : Zahra Hoseinipalangi;Fatemeh Pashazadeh Kan;Hossein Hosseinifard;Maryam Doustmehraban;Maryam Masoumi;Sima Rafiei;Pooyan Barmayoon;Niloofar Ahmadi;Batool Sadat Hoseini;Afsaneh Dehnad;Hajar Eshtod;Mahsa Tohidi Asl;Mahmoud Nasiri;Moslem Arian;Sepideh Aghalou;Ahmad Ghashghaee

Nhà xuất bản : World Health Organization. Regional Office for the Eastern Mediterranean

Năm xuất bản : 2023

Chủ đề : 1. Noncommunicable Diseases. 2. Parkinson Disease -- complications. 3. Quality of Life. 4. Journal / periodical articles.

Chia sẻ

Thông tin chi tiết

Tóm tắt :

Background: Parkinson’s disease can adversely affect the quality-of-life. Aims: We conducted a systematic review and meta-analysis of global literature on the quality-of-life of patients with Parkinson’s disease and examined the association between patient characteristics and quality-of-life. Methods: We searched Embase, PubMed, Scopus and Web of Science from January 2000 to January 2020. We included articles published in English that used the Parkinson’s disease questionnaire to estimate the quality-of-life score and to identify the determinants of quality-of-life in patients with Parkinson’s disease. Results: In total, 41 studies with data from 4060 patients who had Parkinson’s disease met our inclusion criteria. The overall quality-of-life score was 32.37 (95% confidence intervals (CI): 28.72–36.01). Age and duration of disease were inversely related to quality-of-life (P < 0.001). South America had the highest score on the questionnaire (39.73, 95% CI: 28.66–50.79, P < 0.001), indicating the lowest quality-of-life of patients with Parkinson’s disease. Of the 6 World Health Organization regions, the Eastern Mediterranean Region had the highest score (36.28, 95% CI: 23.44–49.13, P < 0.001). Conclusion: Although the global score in patients with Parkinson’s disease indicated an acceptable quality-of-life, there is a possibility for improvements. The findings of this study can inform evidence-based strategies by health policymakers and clinicians to enhance the quality-of-life of patients with Parkinson’s disease.
Chia sẻ


Hiển thị MARC

 Thông tin dữ liệu nguồn

 Thư viện  Ký hiệu xếp giá  Dữ liệu nguồn
Tổ chức y tế thế giới
https://iris.who.int/handle/10665/366200